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Interferon regulatory factors IRF-3 and IRF-7 are central to the establishment of the innate antiviral
response. This study examines HSV-1 pathogenesis in IRF-3−/−, IRF-7−/− and double-deleted IRF3/7−/−
(DKO) mice. Bioluminescence imaging of infection revealed that DKO mice developed visceral infection
following corneal inoculation, along with increased viral burdens in all tissues relative to single knockout
mice. While all DKO mice synchronously reached endpoint criteria 5 days post infection, the IRF-7−/−
mice survived longer, indicating that although IRF-7 is dominant, IRF-3 also plays a role in controlling
disease. Higher levels of systemic pro-inﬂammatory cytokines were found in IRF7−/− and DKO mice
relative to wild-type and IRF-3−/− mice, and IL-6 and G-CSF, indicative of sepsis, were increased in the
DKO mice relative to wild-type or single-knockout mice. In addition to controlling viral replication, IRF-3
and -7 therefore play coordinating roles in modulation of inﬂammation during HSV infection.
& 2013 Elsevier Inc. All rights reserved.Introduction
Herpes simplex virus 1 (HSV-1) is highly sero-prevalent in the
human population (Xu et al., 2006). Its ability to establish latency
renders it refractory to clearance by the immune system, allowing
it to persist for the lifetime of the host (Whitley et al., 1998). HSV-1
infection most commonly manifests as orofacial lesions (Spruance,
1992), but also causes more serious diseases such as stromal
keratitis (Behrens-Baumann, 2010; Hsiao et al., 2009; Inoue,
2008), meningitis, encephalitis (Baringer, 2008; Brochet et al.,
1990; McGrath et al., 1997; Sköldenberg, 1996; Tyler, 2004) and
hepatitis (Al Midani et al., 2011; Riediger et al., 2009). These can
occur during primary infection or reactivation events, particularly
in immune-deﬁcient hosts (Guo et al., 2011; Sancho-Shimizu et al.,
2011, 2007; Zhang et al., 2007).
Type I interferons (IFNα and IFNβ) play major roles in the host
innate immune response to HSV-1 infection, and both humans and
mice lacking components of the IFN pathway show increased suscept-
ibility and mortality during infection with HSV-1 (Guo et al., 2011;
Ishikawa et al., 2009; Lafaille et al., 2012; Luker et al., 2003; Pasieka
et al., 2011, 2008; Sancho-Shimizu et al., 2011; Zhang et al., 2007). The
importance of IFN signaling in the containment of HSV-1 infection is
also reﬂected by the array of proteins encoded by HSV-1 that function
to subvert establishment of the anti-viral state and facilitate viral
replication (Chou et al., 1995; He et al., 1997; Johnson et al., 2008; Lin
et al., 2004; Melroe et al., 2004; Mulvey et al., 2004; Orvedahl et al.,
2007; Pasieka et al., 2012; Sànchez and Mohr, 2007; Xing et al., 2012).ll rights reserved.
Leib).Pattern recognition receptors (PRR) such as toll-like receptors (TLRs)
(Lemaitre et al., 1996), melanoma differentiation factor (MDA5) (Kang
et al., 2002), retinoic acid inducible gene (RIG-I) (Yoneyama et al.,
2004), interferon inducible protein-16 (IFI16) (Unterholzner et al.,
2010), absent in melanoma 2 (AIM2) (Bürckstümmer et al., 2009),
and DNA dependent activator of IRFs (DAI) (Takaoka et al., 2007)
recognize pathogen-associated molecular patterns (PAMPs) such as
dsRNA and viral DNA during infection. Once activated, these PRRs
initiate signaling pathways that culminate in the activation of the
transcription factors IRF-3 and IRF-7, leading to production of type 1
IFN.
IRF-3 is a constitutively expressed protein in most cells, existing as
an inactive monomer in the cytoplasm. Upon activation, serine
residues at the C terminus of IRF-3 are phosphorylated (Hiscott
et al., 1999; Lin et al., 1998; Sharma et al., 2003), IRF-3 assembles into
dimers and translocates to the nucleus (Sato et al., 1998), facilitating
transcription of interferon β. Newly-produced IFNβ secreted from virus
infected cells interacts with cell surface IFNα/β receptors (IFNARs) on
infected and uninfected neighboring cells (Mogensen et al., 1999),
activating the JAK-STAT signaling pathway (Levy and García-Sastre,
2001), inducing transcription of IFN responsive genes including IRF-7
(Fu et al., 1992; Reich, 2007; Zimmerer et al., 2007). The C-terminus of
newly synthesized IRF-7 is phosphorylated, promoting dimerization
and translocation to the nucleus (Sato et al., 2000), where it induces
production of large amounts of IFNα, IFNβ and IFN stimulated genes,
thus establishing the anti-viral state. IRF-7 has long been recognized as
the “master regulator” of interferon signaling (Honda et al., 2005), but
it is also accepted that IRF-3 plays an important role in controlling
HSV-1 replication, particularly within tissues of the central nervous
system (Menachery et al., 2010). In addition to its role in inducing anti-
viral responses, recent reports (Tarassishin et al., 2011a, 2011b) have
Fig. 1. Pattern of viral spread in wild-type, IRF-3−/−, IRF-7−/− and DKO mice. (A) In vivo bioluminescent imaging analysis was performed on days 2 through 5 post corneal
infection with McKrae/DLux. Daily images for the same mice are shown on identical photon ﬂux scales and are representative of 2 independent experiments. (B) Region of
interest analysis of lymph node bioluminescence. ROIs were drawn around the lymph node area using the Living Image and IgorPro software and bioluminescent signal was
reported in photons/s. (C) Viral titers in the blood stream. Serum was isolated from mice two and four days post infection with McKrae/DLux and assayed on vero cell
monolayers (n¼4 mice per group, 2 independent experiments).
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pathology through modulation of pro-inﬂammatory cytokine expres-
sion. Given the non-regenerative nature of certain cell types within the
CNS, this ability to switch from a tissue-damaging pro-inﬂammatory
state to a tissue recovery-promoting, anti-inﬂammatory state is likely
to play a role in successful resolution of infection and recovery of the
host. The study herein utilizes single and double knockout mouse
models of IRF-3 and IRF-7 to examine in detail the roles played by IRF-
3 and IRF-7, both singly and in combination, in controlling HSV-1
replication, and disease pathology.Results
Bioluminescence imaging of mice infected with HSV-1 McKrae/Dlux
Bioluminescence imaging (BLI) has proved useful in several
previous studies (Luker et al., 2003; Pasieka et al., 2011) when
attempting to gain an overview of viral pathogenesis in a variety of
knockout mice. One issue, however, has been that existing biolu-
minescent strains in the HSV-1KOS background are of insufﬁcient
virulence to robustly infect mice in the C57BL/6 background. We
had, however, observed that strain McKrae had a high rate of
lethal infection following corneal challenge of C57BL/6 wild-type
and IRF-3−/− mice (Menachery et al., 2010). We wanted todetermine the roles played by IRF-3 and IRF-7 when faced with
a virulent HSV-1 infection so we created a new luciferase-
expressing virus in the McKrae background (McKraeDlux) and
performed BLI (Fig. 1A and B). Robust photon ﬂux was observed for
all mouse strains at 3, 4, and 5 days post-infection, underscoring
the utility of McKraeDlux. When taken as a whole, BLI signals were
not signiﬁcantly different between C57BL/6 and the single knock-
out mice (IRF3−/−, and IRF7−/−)), although there were trends
towards higher abdominal signals in the IRF-3−/− mice and higher
head/sub-mandibular lymph node signals in the IRF-7−/− mice. In
contrast, imaging of the DKO mice revealed signiﬁcantly higher
photon ﬂuxes in lymph node, eye and abdominal regions relative
to wild-type and single knockout mice at days 3, 4 and 5 post-
infection. Having shown a pattern of increased BLI activity and
generalized spread in the DKO we next wished to assess viremia
during acute infection (Fig. 1C). All mice showed viremia on day 2,
although the DKO mice had almost 10-fold more virus in their
serum than wild-type or single knockout mice. Wild-type and IRF-
3−/− mice were, however, capable of clearing virus from the
bloodstream by day 4. In contrast, the DKO mice were unable to
clear virus from the bloodstream with titers remaining relatively
constant between days 2 and 4. In this time frame, titers decreased
in the blood of IRF-7−/− mice although there was still signiﬁcant
viremia on day 4 post-infection. The widespread viral dissemina-
tion observed on day 5 in the DKO mice by BLI, with especially
Fig. 2. Virus replication in peripheral tissues of wild-type and IRF-3−/−, IRF-7−/−,
and IRF3/7−/− (DKO) mice. Viral titers in (A) cornea, (B) trigeminal ganglia, 4 days
following corneal infection with 2106 pfu/eye. Graphs represent averages and
standard errors of the mean for several mice from two independent experiments
(n≥5 mice per group). The dotted line indicates the threshold of detection.
Statistical analysis (ANOVA) was performed using GraphPad Prism 5.0. Asterisks
indicate ranges of signiﬁcance (nP≤0.05; nnP≤0.01; nnnP≤0.001).
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inability to clear virus from the bloodstream.
Combined IRF-3 and IRF-7 loss leads to enhanced HSV-1 replication
in peripheral tissues
Having established the general patterns of pathogenesis in the
DKO mice using BLI, we wished to examine virus replication more
speciﬁcally in corneas and trigeminal ganglia. For studies which did
not require BLI we switched to infection with wild-type McKrae
virus, but this led to very rapid death (≤4 days) of the DKOmice (data
not shown). We therefore used the less virulent HSV-1 strain 17 for
these experiments to allow the study of HSV-1 replication in these
tissues over a longer time frame. Analysis of corneal swabs (Fig. 2A)
revealed no defect in IRF-3−/− mice for control of HSV-1 replication
on either day 2 (data not shown) or day 4 post infection relative to
wild-type mice, consistent with previously published data
(Menachery et al., 2010). In contrast, HSV replication in corneas of
IRF-7−/− mice was signiﬁcantly increased (p≤0.05) relative to wild-
type, and even greater viral loads (p≤0.001) were observed in the
corneas of DKO mice. Consistent with this, we found the trigeminal
ganglia of DKO infected mice had signiﬁcantly higher viral loads than
wild-type or single knockout mice (Fig. 2B). In contrast to the cornea,
IRF-7−/− mice showed no defect in controlling virus replication in the
trigeminal ganglia. These data show, consistent with the BLI data,
that there is an increase in productive virus infection in corneas and
trigeminal ganglia of DKO mice relative to wild-type or single IRF3/7
knock-out mice.IRF-3 and IRF-7 are both required for control of disease pathology and
lethality
Following infection with HSV-1 strain 17, we monitored mice
for development of disease, and for timing to reach endpoint
disease criteria (Fig. 3A and B). Wild-type and IRF-3−/− mice
displayed a similar degree and rate of disease development, with
symptoms such as eyelid and nasal swelling reaching maximum
levels between 5 and 6 days post infection, and remaining steady,
or declining thereafter. IRF-7−/− mice developed symptoms at a
similar rate to both the wild-type and IRF-3−/− mice up until 5 days
postinfection (Fig. 3A). There was, however, a continued increase
in disease severity, with all IRF-7−/− mice reaching end-point
criteria 6–8 days post-infection (Fig. 3B). DKO mice showed an
increase in both rate of onset and severity of disease symptoms
relative to wild-type or single knockout mice (Fig. 3A). Symptoms
progressed rapidly and all DKO mice reached end point criteria
synchronously on the ﬁfth day post-infection (Fig. 3B). This was
2–3 days earlier than IRF-7 −/− mice, indicating that while IRF-7
may be the critical regulator of IFN responses, IRF-3 becomes
critical for controlling HSV-1 disease progression in the absence of
IRF-7.
We reasoned that the increased mortality in the IRF7−/− and DKO
mice might be due to viral neuroinvasion and encephalitis, as
neurological symptoms were present prior to euthanasia. To examine
whether death correlated with viral titers within the CNS, we
compared viral loads in brain stems and brains of infected mice
(Fig. 3C and D). Interestingly, we observed small but signiﬁcant
increases in viral loads in the brainstems of IRF-3−/− and DKO mice,
relative to wild-type and IRF-7−/− mice. Higher constitutive expres-
sion levels of IRF-3 than IRF-7 within CNS tissue (Christensen et al.,
2012; Delhaye et al., 2006; Ousman et al., 2005), supports IRF-3
having a more important role during the early stages of HSV-1
replication within the CNS, prior to induction of IRF-7. Comparison of
viral loads within the whole brain revealed that only brains from the
DKO mice had signiﬁcantly higher viral loads than wild-type mice
(Fig. 3D). These data are consistent with the hypothesis that while
IRF-3 may be important in controlling initial entry into the brain
stem, IRF-3 and IRF-7 act in concert to limit further virus spread
within the brain. That said, it seemed unlikely that loss of IRF-3/7
leading to increased virus replication in the CNS could be the sole
explanation for the drastic changes in disease and survival seen in
IRF7−/− and DKO mice (Fig. 3A, B).Role of IRF-3 and IRF-7 in migration of immune derived cells
in vitro and production of cytokines in vivo
Previous work has demonstrated that while IRF-3 is important
for control of HSV-1 replication in immune cells, IRF-7 is dis-
pensable (Menachery and Leib, 2009). Consistent with this, virus
replication was increased in IRF-3−/− relative to wild-type and
IRF-7−/− BMDCs, and no additional increases in replication were
observed in the DKO BMDCs (Fig. 4A). In addition to impairments
in controlling viral replication, it has been shown that dendritic
cells of IRF-3−/− mice are impaired in their ability to migrate to
lymph nodes relative to wild-type DCs, possibly leading to sub-
optimal priming of the adaptive immune response (Marichal et al.,
2010). Using an in vitro transwell system, we investigated the
ability of wild-type, IRF-3−/−, IRF-7−/− and DKO BMDCs to migrate
towards CCL19, a chemokine expressed abundantly in lymph
nodes. As expected, IRF-3−/− BMDCs showed defective migration
(Fig. 4B). IRF-7−/− BMDCs exhibited no defect in migration relative
to wild-type, and DKO BMDCs had no additional migratory defects
above those observed in IRF-3−/− BMDCs, indicating that any
defects in migration are due solely to loss of IRF-3.
Fig. 3. Disease, mortality and CNS replication following HSV-1 replication in C57BL6, IRF-3−/−, IRF-7−/− or IRF-3/7−/− (DKO) mice. (A) Pathology following HSV-1 infection.
Corneas of C57BL6, IRF-3−/−, IRF-7−/− and DKO mice were scariﬁed and inoculated with 2106 pfu/eye. Disease scores were recorded in accordance with parameters detailed
in the materials and methods. Data represents disease scores from three independent experiments (n≥12 mice per group). (B) Survival of wild-type, IRF-3−/−, IRF-7−/− and
DKO mice following corneal infection with 2106 p.f.u HSV-1 strain 17 per eye. Survival curves were carried out independent of other studies and represent data from three
individual experiments. (n≥12 mice per group). Brain stems (C) and brains (D) were harvested at speciﬁed days following infection of wild-type, IRF-3−/−, IRF-7−/− and DKO
mice with 2106 p.f.u. HSV-1 strain 17 per eye. Graphs represent mean +/− SEM of two independent experiments, (n≥5 mice per group).
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correlated with altered cytokine levels, we examined plasma of mock
and HSV-1 infected wild-type, IRF-3−/−, IRF-7−/− and DKO mice with a
BioRad Bio-Plex multiple cytokine assay (Fig. 5). While many cytokines
showed elevated expression during infection with HSV-1 we focused
on those which were elevated in the IRF-7−/− and DKO populations,
compared to control and IRF-3−/− mice. Disruption of interferon
signaling can inhibit the IFNγ negative feedback loop, leading to
increased expression of the pro-inﬂammatory cytokine IFNγ (Ben-
Asouli et al., 2002; Kaempfer, 2006). In agreement with this, IFNγ was
only detectable in IRF-7−/− and DKO mice, and expression of MIG
(Farber, 1997), a biomarker for IFNγ activity was also higher in IRF-7−/−
and DKO mice (Fig. 5A). TNFα and IL-1α, pro-inﬂammatory cytokines
which play roles in development of stromal keratitis (Keadle et al.,
2000), were both elevated in IRF-7−/− and DKO relative to wild-type
and IRF-3−/− mice. Interestingly, some anti-inﬂammatory cytokines, IL-
10 and IL-13, were also expressed at higher levels in IRF7−/− and DKO
mice than wild-type and IRF3−/−mice, although the signiﬁcance of this
is unclear (Fig. 5A).
While the elevated levels of the above-mentioned cytokines likely
contribute to the altered pathology observed in infected mice, their
levels were largely equivalent in IRF-7−/− and DKO mice, suggesting
that other factors likely contribute to the especially rapid lethality
observed in the DKO mice. Leukemia inhibitory factor (LIF), a member
of the IL-6 family of proteins with pro- and anti-inﬂammatory
properties (Mathieu et al., 2012), and two pro-inﬂammatory cytokines,
G-CSF and IL-6, had notably high expression levels in DKO mice
relative to IRF-7−/− mice: (Fig. 5A). Elevated levels of G-CSF mobilize
cells from bone marrow and stimulate prolonged survival, leading to
increased numbers of circulating neutrophils (Lawlor et al., 2004; Xu
et al., 1996), while increased IL-6 production in IFN signaling deﬁcient
mice has previously been associated with increased neutrophil
inﬁltration and corneal inﬂammation during HSV-1 infection
(Pasieka et al., 2009). Corneas from DKO mice showed increased
opacity post infection with HSV-1, and real time PCR of corneal tissuesconﬁrmed that transcript levels of IL-6 mRNA were 12 fold higher in
DKO mice relative to wild-type infected mice, while they were only
4 fold higher in IRF-7−/− mice relative to wild-type mice (Fig. 5B). IL-6
transcript levels were also higher in trigeminal ganglia of DKO mice
relative to wild-type mice, than in trigeminal ganglia of IRF-7−/− mice
(Fig. 5B), conﬁrming an elevated IL-6 signaling response in the
peripheral tissues of DKO mice.Discussion
The importance of a timely and measured type 1 IFN response in
the control of HSV-1 infection is well-established (Conrady et al.,
2012; Conrady et al., 2011; Ishikawa and Barber, 2008; Lundberg
et al., 2008; Pasieka et al., 2008, 2009), and defects in the IFN
signaling pathway can lead to life-threatening conditions such as
encephalitis (Lafaille et al., 2012; McGrath et al., 1997; Tyler, 2004).
Interferon regulatory factors 3 and 7 are central to the establish-
ment of this response (Dafﬁs et al., 2008; Honda et al., 2005; Juang
et al., 1998; Marié et al., 1998; Sato et al., 1998), and this study
demonstrates that a combined deﬁciency of IRF-3 and IRF-7 results
in a rapid onset, severity and progression of disease pathology,
along with increased mortality following infection with HSV-1. That
said, the deletion of IRF-7 alone had a signiﬁcant impact on
pathogenesis, especially on viremia and mortality, and the impact
of IRF-7 loss was greater than the impact of loss of IRF-3 alone. This
non-redundancy of IRF-3 and 7 is similar to the pattern observed
for West Nile virus (Dafﬁs et al., 2008), but distinct from observa-
tions with Chikungunya and murine norovirus (Schilte et al., 2012;
Thackray et al., 2012) in which signiﬁcant changes in susceptibility
were observed only after deletion of both IRF-3 and -7.
Despite evidence for a dominant role for IRF-7, this study has
revealed that IRF-3 and IRF-7 act synergistically to exert control over
viral replication, with signiﬁcantly elevated viral burdens in all tissues
examined in DKO relative to single knockout mice. Altered tissue
Fig. 4. HSV replication in wild-type and IRF-3−/−, IRF-7−/−, and IRF3/7−/− (DKO)
BMDCs and impact on DC migration. (A) In vitro replication in bone marrow
derived dendritic cells. Primary BMDCs were infected with HSV-1 strain 17 at MOI
1. At indicated times post infection, cell supernatants were harvested and viral
titers assayed on vero cell monolayers. Results shown represent the mean +/− SEM
of two independent experiments, each carried out in triplicate. (B) Migratory ability
of primary BMDCs. The ability of wild-type, single and DKO BMDCs to migrate
towards the chemokine CCL19 was determined by counting the number of cells
which migrated through a 2 mm pore size polycarbonate ﬁlter of a transwell plate.
Results shown represent one experiment carried out in duplicate. The experiment
was repeated twice with identical results. Statistical analysis (ANOVA) was
performed using GraphPad Prism 5.0. (nP≤0.05; nnP≤0.01; nnnP≤0.001).
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with a previous study characterizing WNV infection of DKO mice
(Dafﬁs et al., 2009). Although 100% mortality was observed in DKO
mice in both studies, the earlier invasion of virus into the CNS and the
lethal uncontrolled viral replication that was observed during WNV
infection was not recapitulated during HSV infection. Based on the BLI
study it appears more likely that the susceptibility of the DKO mice is
largely due to the profound viscerotropism of HSV-1 in the absence of
IRF-3 and -7, consistent with the pattern of HSV infection in IFNR−/−
mice (Luker et al., 2003). Such patterns of infection are accompanied
with alterations in AST/ALT levels within the livers of both experi-
mental mice and in humans resulting in herpetic hepatitis and fatal
liver failure (Minuk and Nicolle, 1986; Norvell et al., 2007).
Previous studies have demonstrated that loss of critical compo-
nents of the IFN signaling pathway, such as STAT1, can lead to
enhanced inﬂammation and pathology during infection with HSV-1,
and such disease can be independent of changes in viral titers
(Lundberg et al., 2008; Pasieka et al., 2008, 2009). Several studies
have also reported that IRF-3 has anti-inﬂammatory propertieswhich may help control immune-mediated pathology (Hua et al.,
2002; Suh et al., 2009; Tarassishin et al., 2011a, 2011b). These
studies therefore prompted us to investigate in this study whether a
dysfunctional immune response was contributing to the observed
pathology and mortality. Consistent with this idea, cytokine proﬁl-
ing revealed higher levels of systemic pro-inﬂammatory cytokines
in IRF7−/− and DKOmice relative to wild-type and IRF-3−/−mice. IL-6
and G-CSF, which lead to increased inﬁltration of immune cells into
tissues and increased pathology (Fielding et al., 2008; Lawlor et al.,
2004; Xu et al., 1996; Yong, 1996) have previously been implicated
in the development of herpes stromal keratitis (Divito and
Hendricks, 2008; Fenton et al., 2002; Inoue, 2008). Consistent with
this, we observed high levels of IL-6 transcripts in the corneas of
DKO mice, indicating that it likely contributes to the ocular and
periocular pathology that occurs during infection in these mice.
Studies have also shown a negative correlation between IL-6 levels
and survival of herpes simplex encephalitis (Bociąga-Jasik et al., 2011).
Additionally, elevated levels of LIF (Auernhammer and Melmed, 2000;
Villers et al., 1995), IL-6 (Damas et al., 1997; Ebong et al., 1999) and G-
CSF have all been reported during the development of systemic
inﬂammatory response syndrome, or sepsis. Sepsis is characterized
by an initial hyper-inﬂammatory response to infection, which can be
followed by a period of immune suppression (Hotchkiss et al., 2009),
and is associated with development of organ dysfunction, hypoperfu-
sion or hypotension and intravascular coagulation (Sriskandan and
Altmann, 2008). Anti-inﬂammatory cytokines are also produced dur-
ing sepsis as the host attempts to modulate the inﬂammatory
response (Marchant et al., 1994), perhaps explaining our observation
of elevated levels of IL-10 and IL-13. Interestingly, the pathophysiology
of neonatal HSV infection is typical of a systemic inﬂammatory
response, and it has been reported that neonates, whose immune
systems are immature in comparison to the adult immune system,
produce higher quantities of pro-inﬂammatory cytokines such as IL-6
in response to HSV challenge. This correlates well with our observa-
tions that deﬁciencies in the innate immune response lead to
uncontrolled inﬂammation and sepsis, and indicate that this may be
a useful model for further study of neonatal HSV pathology.
While our data supports the development of a hyper-inﬂammatory
state in IRF-3/7−/− deﬁcient mice, it contrasts with a previous study
which reported increased expression of transcripts encoding multiple
inﬂammatory markers within the CNS of STAT1−/− mice with an
accompanying breach of the blood brain barrier (Pasieka et al.,
2009). In this study we analyzed expression of cytokines and markers
of inﬂammation in brain stem tissues. Surprisingly, we found no
evidence of further elevation of proinﬂammatory cytokines in the
brains of the DKO mice relative to the other mice (data not shown).
We also found no evidence of increased cellular inﬁltrates or breach of
the blood-brain barrier (data not shown). These data suggest that the
elevated cytokines observed in the DKOmice are causing their damage
outside of the CNS, most likely coupled with the signiﬁcant general-
ized infection visualized through the BLI experiments. In the absence
of IRF-3 and IRF-7, it is possible that the initial hyperinﬂammatory
phase of sepsis is so rapid that death ensues before the development
of breach of the BBB.
In summary, our study has revealed that while IRF-7 is the
dominant factor in the control of HSV-induced disease and
mortality, IRF-3 and IRF-7 act synergistically to control viral
replication, with loss of both leading to higher viral loads. We
also demonstrate that they play an essential role in modulation of
inﬂammatory responses during infection with HSV, preventing the
development of severe systemic inﬂammation. It is likely that a
combination of increased viral replication and markedly increased
levels of pro-inﬂammatory cytokines such as G-CSF and IL-6 in the
DKO mice are responsible for the increased disease and mortality
observed. These mice will therefore likely prove a useful model for
future studies of sepsis and immune pathology.
Fig. 5. Cytokine analysis from sera of wild-type, IRF-3−/−, IRF-7−/−, and IRF3/7−/−mice following HSV infection. (A) Multiplex cytokine analysis of plasma from HSV-1 infected wild-
type, IRF3−/−, IRF7−/− and DKOmice. Mice were infected by corneal scariﬁcation and bloodwas harvested 4 days pi. Average concentrations from groups of 3 mice are reported as pg/ml.
Mock samples were omitted from the graphs for clarity. (B) Transcript levels of IL-6 within corneal and trigeminal tissue. RNA was extracted from corneas and trigeminal ganglia of
wild-type, IRF-3−/−, IRF-7−/− and DKO mice 4 days post infection with HSV-1 strain 17. After conversion to cDNA, transcript levels of IL-6 in knockout mice were compared to levels in
wild-type mice. Graphs represent means (+/− SEM) from three biological replicates. Each biological replicate was subjected to three technical replicates.
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Cell culture and viruses
Vero cells, maintained in Dulbecco's Modiﬁcation of Eagle
Medium (DMEM) supplemented with 10% v/v fetal bovine serum(FBS) and 1% penicillin/streptomycin were used to propagate and
titer HSV-1 preparations. Bone marrow derived dendritic cells
(BMDCs) were generated from 6 to 8 week old wild-type, IRF-3−/−,
IRF-7−/− and IRF-3/7−/− mice. Brieﬂy, bone marrow was ﬂushed
from femurs and cultured in RPMI supplemented with 10% FBS,
glutamax, sodium pyruvate, non-essential amino acids, 1%
A.A. Murphy et al. / Virology 444 (2013) 71–79 77penicillin/streptomycin and 2% granulocyte macrophage colony
stimulating factor (GM-CSF) for 7 days. BMDCs were harvested and
divided into aliquots for infection. Virus was added in a minimal
volume of medium for 1 h at 37 1C. After 1 h adsorption, cells were
centrifuged at low speed, washed and re-suspended in fresh
medium in 6 well plates for the duration of the experiment.
HSV-1 strain 17 syn+ (Brown et al., 1973) and HSV-1 McKrae/Dlux
were used in this study. McKrae/Dlux was generated through homo-
logous recombination of HSV-1 McKrae strain infectious DNA with a
pUIC plasmid containing a pDlux cassette, as previously described
(Summers et al., 2001). Recombinant viruses were screened for
luciferase expression, plaque puriﬁed three times and veriﬁed by
Southern blot (data not shown). All viral stocks were titered by plaque
assay on vero cell monolayers as described previously (Leib et al.,
1989). Brieﬂy, serial 10-fold dilutions of virus were applied to cell
monolayers, adsorbed for 1 h and overlaid with a semi-solid methyl-
cellulose overlay. After 4 days monolayers were stained with neutral
red and plaques were counted.
Migration assay
Chemotaxis in response to CCL19 was analyzed by measuring
the number of cells migrating through a polycarbonate ﬁlter in
transwell chambers (2 mm pore size; Corning). 3105 wild-type,
IRF-3−/−, IRF-7−/− or DKO BMDCs were seeded into the top
chambers of the transwells in culture medium. Culture medium
supplemented with 20 ng/ml of CCL19 was added to the bottom
chambers. Cultures were incubated for 3 h at 37 1C and cells that
migrated from the top to the bottom chamber were counted using
an automated cell counter.
Mice
Mouse strains used in this study included wild-type C57BL6 mice
and IRF-3−/− (Sato et al., 2000), IRF-7−/− (Honda et al., 2005) and IRF-3/
7−/− (generated by crossing IRF-3−/− X IRF-7−/− single knockout mice)
knockout, referred to hereafter as DKO (double knockout) strains, all
on the C57BL6 background. Mice were genotyped by PCR and housed
in the barrier facility in the Center for Comparative Medicine and
Research at The Geisel School of Medicine at Dartmouth and were
infected in the biohazard facility between the ages of 6–8 weeks. Mice
were housed, treated, and euthanized when necessary in accordance
with all Federal and University policies.
Animal infection, disease scoring and organ harvest
Mice were anesthetized intraperitoneally with ketamine (87 mg/
kg body weight) and xyalazine (13 mg/kg). Corneas were bilaterally
scariﬁed and mice were inoculated by adding 2106 pfu per eye in a
5 μl volume (Rader et al., 1993). At indicated times post infection,
mice were weighed and scored for disease pathology using the
following disease scores: 0—no visible pathology, 0.5—minor eyelid
swelling, 1.0—minor eyelid and nasal swelling, 1.5—moderate eyelid
and nasal swelling, 2.0—severe eyelid swelling, minor periocular hair
loss and skin lesions, 2.5—severe eyelid swelling, moderate perio-
cular hair loss and skin lesions, 3.0—neurological symptoms. End-
point criteria for sacriﬁcing mice for mortality include loss of ≥15% of
starting body weight, altered locomotion, and labored breathing. Eye
swab material was collected for analysis by plaque assay at selected
times post infection, as previously described (Leib et al., 1989). Mice
were sacriﬁced and trigeminal ganglia, brain stems, brains, livers and
spleens were harvested into an appropriate volume of media,
mechanically disrupted with either 1 mm or 2.5 mm glass beads,
sonicated and titered via standard plaque assay (Menachery et al.,
2010).Bioluminescence imaging
Mice infected with McKrae/Dlux were injected intraperitoneally
with 150 μg/g body weight of D-Luciferin potassium salt (GoldBio) in
PBS, anaesthetized with 2.5% isoﬂurane and imaged (exposure time
of 1–60 s, f-stop 1 or 2, ﬁeld of view 15 or 19.6) with a cooled charge
coupled device (CCD) camera based bioluminescence in vitro ima-
ging system (IVIS 100, Caliper Life Sciences, Hopkinton, MA) (Pasieka
et al., 2011). For analysis, regions of interest (ROI) were deﬁned
manually around eyes, lymph nodes and liver. Background light
emission was subtracted from ROIs and photon ﬂux was calculated
using Living Image and Igor pro software (Version 2.6).
Cytokine analysis
Blood was harvested from mice at indicated times post infec-
tion and plasma was separated by centrifugation. For this experi-
ment, a mouse 32-plex kit (Milipore) was utilized. Samples were
diluted 1:1 with assay buffer, and processed as per manufacturers
instructions. Cytokines concentrations were determined by com-
parison to recombinant cytokine standard curves.
Real time reverse transcription PCR of tissue
At the indicated time post infection tissues were harvested into
Trizol (Invitrogen). Tissue was homogenized using a tissue blender,
RNA was extracted as per manufacturers instructions and DNAse
treated with DNA-free (Ambion). cDNA was generated with super-
script III reverse transcriptase (Invitrogen) using random hexam-
ers to prime the reaction. Efﬁciency curves were generated for all
primer sets to determine PCR efﬁciencies of target and reference
genes, as described by Pfafﬂ (2001). PCR mixtures were prepared
with iQ SYBR green supermix (Biorad), 0.2–0.5 μM primers, and
2 μl cDNA. For each ampliﬁed PCR product, a single peak was
obtained by melting curve analysis, and only a single band of the
predicted size was observed by agarose gel electrophoresis. The
Pfafﬂ method (Pfafﬂ, 2001), which takes PCR efﬁciencies into
account, was used for data analysis.Acknowledgments
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